Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature
- PMID: 28374865
- PMCID: PMC5384304
- DOI: 10.14639/0392-100X-1195
Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature
Abstract
Central lymph node metastases are common in patients with differentiated thyroid cancer (DTC). The management of preoperatively nodenegative (cN0) DTC is still under debate. The aim of this study was to analyse the difference in recurrence and surgical complications between thyroidectomy (TT) alone and TT combined with prophylactic central neck dissection (pCND) as initial treatments to DTC patients with cN0 and evaluate the clinic significance of pCND for these patients. PubMed, Ovid, Cochrane Library, and Web of Science databases were systematically searched using multiple search terms. Twenty-three articles with 6,823 patients were identified. The quality of evidence was assessed by Jadad quality scores and the Newcastle-Ottawa Quality assessment scale. The results showed that compared with patients who underwent TT alone, patients who underwent TT plus pCND had a significant higher rate of transient recurrent laryngeal nerve injury (p = 0.023), transient hypocalcaemia (p < 0.01) and permanent hypocalcaemia (p<0.01). There was a trend towards lower central neck recurrence rate in TT plus pCND (p < 0.01). Combined TT and pCND as initial treatment for DTC patients with cN0 may reduce the risk of recurrence, but increases the incidence of some complications. Methodologically high-quality comparative studies are needed for further evaluation.
Le metastasi ai linfonodi del compartimento centrale del collo sono comuni nei pazienti affetti da carcinoma differenziato della tiroide (DTC). La gestione dei pazienti con stadiazione preoperatoria cN0 è ancora dibattuta. L’obiettivo di questo lavoro è stato quello di analizzare le differenze in merito a ricorrenza e complicanze chirurgiche tra tiroidectomia (TT) isolata e TT associata a svuotamento linfonodale profilattico del compartimento centrale del collo (pCND) come trattamenti iniziali di pazienti con DTC cN0, e di valutare l’importanza clinica del pCND per questi pazienti. I database PubMed, Ovid, Cochrane Library e Web of Science sono stati analizzati scrupolosamente, e sono stati identificati ventitré articoli per un totale di 6823 pazienti. La qualità di evidenza è stata valutata tramite lo score di Jadad e tramite la Newcastle-Ottawa Quality assessment scale. I risultati hanno mostrato che i pazienti sottoposti a TT e pCND, se paragonati ai pazienti sottoposti a TT isolata, hanno avuto un tasso significativamente più alto di lesioni transitorie del nervo laringeo inferiore (p = 0,023), di ipocalcemia transitoria (p < 0,01) e di ipocalcemia permanente (p < 0,01). Inoltre è stato rilevato un trend in diminuzione per quel che riguarda il tasso di ricorrenza nei pazienti sottoposti a TT e pCND (p < 0,01). La tiroidectomia totale associata allo svuotamento del compartimento centrale del collo come trattamento iniziale per quei pazienti con cN0 potrebbe ridurre il rischio di ricorrenza di malattia, ma aumenta l’incidenza di alcune complicanze. Si rendono necessari ulteriori studi di maggior qualità metodologica.
Keywords: Differentiated thyroid cancer; Meta-analysis; Prophylactic central neck dissection; cN0.
© Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy.
Figures
Similar articles
-
Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.Bull Cancer. 2016 Jun;103(6):535-40. doi: 10.1016/j.bulcan.2016.04.003. Epub 2016 May 25. Bull Cancer. 2016. PMID: 27236850
-
Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis.Eur J Surg Oncol. 2017 Nov;43(11):1989-2000. doi: 10.1016/j.ejso.2017.07.008. Epub 2017 Aug 3. Eur J Surg Oncol. 2017. PMID: 28807633 Review.
-
Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.Int J Surg. 2017 May;41 Suppl 1:S40-S47. doi: 10.1016/j.ijsu.2017.01.113. Int J Surg. 2017. PMID: 28506412
-
Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.Nucl Med Commun. 2017 Dec;38(12):1036-1040. doi: 10.1097/MNM.0000000000000756. Nucl Med Commun. 2017. PMID: 28953211
-
Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysis.Front Endocrinol (Lausanne). 2023 Jul 27;14:1176512. doi: 10.3389/fendo.2023.1176512. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37576962 Free PMC article.
Cited by
-
Extent of thyroid surgery for clinically node-negative papillary thyroid carcinoma with confirmed nodal metastases after prophylactic central neck dissection: a 15-year experience in a single center.Ann Surg Treat Res. 2020 Oct;99(4):197-204. doi: 10.4174/astr.2020.99.4.197. Epub 2020 Sep 24. Ann Surg Treat Res. 2020. PMID: 33029478 Free PMC article.
-
Role of prophylactic central neck lymph node dissection for papillary thyroid carcinoma in the era of de-escalation.World J Clin Oncol. 2023 Jul 24;14(7):247-258. doi: 10.5306/wjco.v14.i7.247. World J Clin Oncol. 2023. PMID: 37583949 Free PMC article. Review.
-
Surgical approach to level VI in papillary thyroid carcinoma: an overview.Updates Surg. 2017 Jun;69(2):205-209. doi: 10.1007/s13304-017-0468-2. Epub 2017 Jun 13. Updates Surg. 2017. PMID: 28612210 Review.
-
Protocol for the development of a global core outcome set for the surgical treatment of differentiated thyroid cancer: a literature review and international Delphi survey.BMJ Open. 2025 Jan 11;15(1):e084391. doi: 10.1136/bmjopen-2024-084391. BMJ Open. 2025. PMID: 39800407 Free PMC article.
-
Adequacy and Effectiveness of Watson For Oncology in the Treatment of Thyroid Carcinoma.Front Endocrinol (Lausanne). 2021 Mar 3;12:585364. doi: 10.3389/fendo.2021.585364. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33746898 Free PMC article.
References
-
- Pacini F, Castagna MG, Brilli L, et al. Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(Suppl 4):143–146. - PubMed
-
- Lang BH, Lo CY, Chan WF, et al. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging. Ann Surg Oncol. 2007;14:730–738. - PubMed
-
- Palestini N, Borasi A, Cestino L, et al. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg. 2008;393:693–698. - PubMed
-
- Rosenbaum MA, McHenry CR. Central neck dissection for papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2009;135:1092–1097. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical